Trends in Inferior Vena Cava Filter Placement by Indication in the United States From 2005 to 2014

Abstract

This population-based study examines the change in the rates of inferior cava filter placement in US inpatients from 2005 to 2014.

Figure 1.. Rates of Inpatient Inferior Vena Cava Filter (IVCF) Placement

A, Rates with and without thromboembolism (TE) per 100 000 hospital discharges by year. B, Rates with and without contraindications to anticoagulation (eg, intracranial bleeding, other major bleeding, thrombocytopenia, active gastrointestinal tract ulcer, hemophilia, von Willebrand disease, cerebral aneurysm, aortic dissection, pericardial disease, bacterial endocarditis, preeclampsia or eclampsia, malignant hypertension, brain surgery, spinal surgery, or eye surgery) per 100 000 hospital discharges by year. DVT indicates deep vein thrombosis without pulmonary embolism; PE, pulmonary embolism; and proph, prophylactic.

Figure 2.. Inpatient Inferior Vena Cava Filter Placement Rates per 100 000 Hospital Discharges

Data from 2014 US Census Division. New England: Connecticut, Maine, Massachusetts, New Hampshire,^a Rhode Island, and Vermont. Mid-Atlantic: New Jersey, New York, and Pennsylvania. South Atlantic: Delaware,^a District of Columbia, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, and West Virginia. East North Central: Illinois, Indiana, Michigan, Ohio, and Wisconsin. West North Central: Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota. East South Central: Alabama,^a Kentucky, Mississippi,^a and Tennessee. West South Central: Arkansas, Louisiana, and Oklahoma, and Texas. Mountain: Arizona, Colorado, Idaho,^a Montana, Nevada, New Mexico, Utah, and Wyoming. Pacific: Alaska,^a California, Hawaii, Oregon, and Washington. ^aDid not contribute 2014 data.